By the end of last year, if you needed a coronavirus test, you could get one. But when vaccines arrived, focus shifted.
Many of the vaccinated felt like they didn’t need tests and demand took a nosedive. Testing sites were closed or converted into vaccination sites. And Abbott Laboratories, a major test manufacturer, wound up destroying millions.
However, with the surge of the new Omicron variant, which is less susceptible to vaccines, demand for testing is back — and it is outstripping supply.
Guest: Sheryl Gay Stolberg, a Washington correspondent, covering health policy for The New York Times.
- President Biden came into office vowing to make coronavirus testing cheap and accessible, but matching supply with demand has been a persistent problem.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.